Explore the full directors' dealings record of Alpha Tau Medical Ltd., a listed issuer based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). Market capitalisation: €1.1bn. The latest transaction was reported on 1 July 2026 (Cession). Among the most active insiders: Levy Raphi. The full history is free.
7
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
€303,171
7 ops.
Sell Volume
24Σ signal
Buys ·€303,171 Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
15,000 shares@ US$10.757145.8% of flowOrdinary SharesSEC:0001213900-26-065201:1
7 of 7 declarations
About Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd. is a company focused on developing innovative cancer treatments using alpha radiation therapy technology. It is listed on NASDAQ under the ticker ATOU.